What is the origin of ulcerative colitis? Still more questions than answers

Por Lukas, Milan, Bortlik, Martin, Maratka, Zdenek
Publicado em 2006

Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases

Por Malíčková, Karin, Ďuricová, Dana, Bortlík, Martin, Janatková, Ivana, Zima, Tomáš, Lukáš, Milan
Publicado no Auto Immun Highlights (2012)

Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases

Por Park, Sang Hyoung, Park, Jae Cheol, Lukas, Milan, Kolar, Martin, Loftus, Edward V.
Publicado no Intest Res (2020)

Deficiency of Adenomatous Polyposis Coli protein in sporadic colorectal adenomas and its associations with clinical phenotype and histology

Por Bortlík, Martin, Vítková, Ivana, Papežová, Martina, Kohoutová, Milada, Novotný, Aleš, Adamec, Stanislav, Chalupná, Petra, Lukáš, Milan
Publicado em 2006

Vedolizumab Efficacy, Safety, and Pharmacokinetics With Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients With Crohn’s Disease or Ulcerative Colitis

Por Vermeire, Séverine, Lukáš, Milan, Magro, Fernando, Adsul, Shashi, Lindner, Dirk, Rosario, Maria, Roth, Jeannine, Danese, Silvio
Publicado no J Crohns Colitis (2020)

The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease

Por Hradsky, Ondrej, Dusatkova, Petra, Lenicek, Martin, Bronsky, Jiri, Nevoral, Jiri, Vitek, Libor, Lukas, Milan, Zeniskova, Ivana, Cinek, Ondrej
Publicado em 2010

Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases

Por Malíčková, Karin, Ďuricová, Dana, Bortlík, Martin, Hrušková, Zdenka, Svobodová, Barbora, Machková, Naděžda, Komárek, Viktor, Fučíková, Terezie, Janatková, Ivana, Zima, Tomáš, Lukáš, Milan
Publicado em 2011

Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers

Por Malíčková, Karin, Francová, Irena, Lukáš, Milan, Kolář, Martin, Králíková, Eva, Bortlík, Martin, Ďuricová, Dana, Štěpánková, Lenka, Zvolská, Kamila, Pánková, Alexandra, Zima, Tomáš
Publicado no Pract Lab Med (2017)

Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis

Por Kverka, Miloslav, Rossmann, Pavel, Tlaskalova-Hogenova, Helena, Klimesova, Klara, Jharap, Bindia, de Boer, Nanne K, Vos, Rene M, van Bodegraven, Adriaan A, Lukas, Milan, Mulder, Chris J
Publicado em 2011

Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis

Por Atreya, Raja, Bloom, Stuart, Scaldaferri, Franco, Gerardi, Viviana, Admyre, Charlotte, Karlsson, Åsa, Knittel, Thomas, Kowalski, Jan, Lukas, Milan, Löfberg, Robert, Nancey, Stephane, Petryka, Robert, Rydzewska, Grazyna, Schnabel, Robert, Seidler, Ursula, Neurath, Markus F., Hawkey, Christopher
Publicado no J Crohns Colitis (2016)

NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients

Por Meggyesi, Nora, Kiss, Lajos S, Koszarska, Magdalena, Bortlik, Martin, Duricova, Dana, Lakatos, Laszlo, Molnar, Tamas, Leniček, Martin, Vítek, Libor, Altorjay, Istvan, Papp, Maria, Tulassay, Zsolt, Miheller, Pal, Papp, Janos, Tordai, Attila, Andrikovics, Hajnalka, Lukas, Milan, Lakatos, Peter Laszlo
Publicado em 2010